Creative Touch Permanent Makeup and Aesthetics

Epidermal growth factor (EGF) is the primary re-epithelialisation signal in skin wound healing. Its defining function is driving keratinocyte migration across the wound bed to restore the epidermal barrier after injury. What makes EGF particularly clinically relevant in aged skin is not that keratinocytes lose the ability to respond to it, but that aged wounds produce less of it: EGFR signalling declines with age because the wound environment generates fewer EGF ligands, not because the receptors fail. Providing exogenous EGF into an aged wound environment (through iPRF, or alongside fractional laser) restores a signal the tissue is still capable of acting on but is no longer receiving in adequate quantities.

Epidermal growth factor is a 53- amino acid peptide that signals through the epidermal growth factor receptor (EGFR) – a receptor tyrosine kinase expressed on keratinocytes, dermal fibroblasts, and endothelial cells throughout the skin. ^[4] In acute wounds, EGF is secreted by platelets, macrophages, and fibroblasts within a short period following injury, acting on keratinocytes in a paracrine fashion to initiate the cellular responses that restore epidermal continuity.

Despite its name, EGF’s most critical function in wound healing is not proliferation but migration, and the distinction matters. Re-epithelialisation, the process of restoring epidermal coverage across a wound, is rate-limited by how quickly keratinocytes can move across the wound bed, not by how quickly new keratinocytes are produced. EGF accelerates that movement independently of its proliferative effects: EGF-stimulated keratinocyte locomotion velocity increases even when cell division is separately blocked. ^[1]

The Migration Mechanism: Integrins and Kindlin-1

EGF drives keratinocyte migration through EGFR activation of the ERK/MAPK pathway, which upregulates Kindlin-1 – an intracellular adaptor protein that activates integrin β1 on the keratinocyte surface. spandidos-publications.com Integrin β1 activation enables keratinocytes to form traction contacts with the ECM – specifically with the type I collagen and fibronectin of the wound bed – and pull themselves across it in coordinated sheets. Without this integrin-mediated ECM traction, keratinocytes cannot migrate efficiently regardless of the motility signal they receive.

This is why the quality of the ECM substrate matters as much as EGF availability for re-epithelialisation speed. In MMP-degraded or fragmented ECM (as in chronically photodamaged skin) the traction surface that integrin β1 would grip is compromised, and EGF-driven migration is impaired not because EGF is absent but because the substrate it would move across is inadequate. Polynucleotide-mediated MMP suppression, described in the Polynucleotides entity, addresses this substrate problem – another dimension of the environment-first logic that applies to EGF-dependent re-epithelialisation as much as to PDGF-driven fibroblast recruitment.

The EGF Migration Machinery

The Ageing Problem: Ligand Depletion, Not Receptor Failure

One of the most clinically important findings in the EGF and ageing literature is that the age-related decline in wound healing associated with EGFR is extrinsic rather than intrinsic to the keratinocyte. Wound healing experiments confirmed that aged wounds showed significantly reduced EGFR phosphorylation – the activation signal that triggers keratinocyte migration – but when aged keratinocytes were cultured with exogenous EGF, they responded with normal colony expansion and migration capacity, indistinguishable from young keratinocytes. rupress.org The problem is not that aged keratinocytes cannot respond to EGF, rather that aged wound environments produce less of it. Age-related decreases in EGF have been measured in urinary excretion, serum, and burn wound fluid in humans. rupress.org

Separately, EGFR density itself is measurably lower in aged skin than in young controls, confirmed through observations of patients treated with EGFR inhibitor drugs, who developed accelerated skin ageing features including xerosis, epidermal atrophy, and rhytide formation within weeks of treatment onset. ^[3] The senescence-associated secretory phenotype triggered by pharmacological EGFR inhibition – upregulated p21, p53, and IL-6; G1 cell cycle arrest – closely mirrors intrinsic skin ageing features, establishing that healthy EGFR signalling is not just a wound healing mechanism but a maintenance requirement for preventing the epidermal thinning and fragility associated with aged skin. ^[3]

Intrinsic vs. Extrinsic Ageing (The EGF Lesson)

EGF Beyond Re-Epithelialisation: Fibroblasts, HA, and Melanogenesis

Whilst re-epithelialisation is EGF’s primary wound healing function, EGFR is expressed on dermal fibroblasts as well as keratinocytes. EGF stimulates fibroblast migration and, in aged skin specifically, increases fibroblast synthesis of hyaluronic acid and collagen. ^[2] Injected recombinant human EGF (rhEGF) in clinical studies has shown induction of collagen, elastin, and hyaluronic acid in aged skin alongside the re-epithelialisation effects, though it is important to calibrate this evidence honestly: the majority of rhEGF aesthetic studies are uncontrolled or non-randomised, and the evidence is insufficient to establish efficacy for anti-ageing applications with the same confidence as the wound healing mechanism. ^[6] The wound healing evidence base is robust; the aesthetic skin restructuring evidence base is promising but not yet at the same level.

EGF also has a well-evidenced effect on melanogenesis that is directly relevant to post-procedure pigmentation management. It acts on melanocytes by reducing expression of tyrosinase and MITF, the key regulatory proteins in melanin synthesis, and has been shown in clinical studies to prevent post-inflammatory hyperpigmentation following fractional carbon dioxide laser treatment, with daily application producing significant stimulation of healing and reduced hyperpigmentation at three, seven, and 35 days post-laser. ^[6] This anti-melanogenic effect makes EGF delivery post-thulium laser treatment a clinically rational step for higher-Fitzpatrick-type clients where post-inflammatory hyperpigmentation is a concern.

Sustained Delivery vs Bolus: Why the Fibrin Matrix Matters for EGF

The delivery format of EGF significantly affects its re-epithelialisation outcome. Immobilised EGF – presented in a sustained, substrate-bound format rather than as a soluble bolus – produces better collective keratinocyte sheet migration than soluble EGF delivered as a single dose. ^[5] The mechanism is that sustained EGFR activation drives different intracellular trafficking patterns than brief pulse activation. Prolonged receptor engagement maintains the PLCγ1 signalling that drives persistent directed migration, rather than the receptor internalisation and signal attenuation that follows a brief soluble EGF pulse.

This is directly relevant to iPRF’s delivery format. The fibrin scaffold releases EGF over days rather than immediately, a sustained delivery profile that is mechanistically better matched to the collective keratinocyte migration timescale than a bolus application would be. Standard PRP, without the fibrin matrix of iPRF, delivers its growth factor payload more acutely, releasing more of the total EGF content earlier, which then degrades before re-epithelialisation of the treatment zone is complete.